Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBP.L Regulatory News (CBP)

  • There is currently no data for CBP

Form 8 (OPD) - Nucleus Financial Platforms Limited

9 Dec 2022 07:00

RNS Number : 1347J
Nucleus Financial Platforms Limited
09 December 2022
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Nucleus Financial Platforms Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Curtis Banks Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

8 December 2022

 

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

ORDINARY SHARES OF 0.5p EACH

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Interests in ordinary shares of 0.5 pence each in Curtis Banks Group plc held by persons acting in concert with Nucleus Financial Platforms Limited

Name

Number of ordinary shares

Percentage of issued share capital (per cent.)

N/A

N/A

N/A

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

09 December 2022

Contact name:

Alice Dixie, Nucleus Financial Platforms Limited

Telephone number:

+44 (0)77 0255 5615

 

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEETPBPTMTBMBMT
Date   Source Headline
1st Nov 20214:35 pmRNSPrice Monitoring Extension
21st Oct 20214:41 pmRNSHolding(s) in Company
21st Oct 20212:48 pmRNSHolding(s) in Company
20th Oct 20213:08 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSDirector/PDMR Dealing
11th Oct 20219:38 amRNSDirector/PDMR Dealing
22nd Sep 20211:00 pmRNSDividend Timetable
9th Sep 20217:00 amRNSInterim Results
1st Sep 20214:35 pmRNSTR-1: Notification of major holdings
19th Jul 20217:00 amRNSTrading Update
25th Jun 20213:00 pmRNSHolding(s) in Company
9th Jun 20217:00 amRNSTR1: Notification of Major Holdings
8th Jun 20212:55 pmRNSDirector/PDMR Shareholding
3rd Jun 20212:03 pmRNSDirector/PDMR Shareholding
27th May 20214:40 pmRNSResult of AGM
12th May 20215:11 pmRNSCorrection to Notice of Annual General Meeting
30th Apr 20217:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20217:00 amRNSDirector/PDMR Shareholding
19th Apr 20214:24 pmRNSDirector/PDMR Shareholding
12th Apr 20215:37 pmRNSDirector/PDMR Shareholding
8th Apr 20215:59 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSFinal Results
17th Mar 20217:00 amRNSUpdate on Timing of Full Year Results Announcement
5th Feb 202110:12 amRNSHolding(s) in Company
19th Jan 20217:00 amRNSAppointment of Non-Executive Director
12th Jan 20217:00 amRNSTrading Update
18th Dec 20207:00 amRNSDirector/PDMR Shareholding
30th Nov 20207:00 amRNSTrading and Operations Update
26th Nov 20204:49 pmRNSHolding(s) in Company
13th Nov 20204:33 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
28th Oct 202010:00 amRNSDirector/PDMR Shareholding
6th Oct 20207:00 amRNSCompletion of acquisition of Talbot and Muir
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSLong-Term Incentive Plan
7th Sep 20207:01 amRNSInvestor Presentation
7th Sep 20207:00 amRNSDividend timetable
3rd Sep 20207:00 amRNSInterim Results
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
4th Aug 20207:00 amRNSNotice of Results
30th Jul 202012:26 pmRNSHolding(s) in Company
28th Jul 20209:20 amRNSHolding(s) in Company
27th Jul 20206:14 pmRNSHolding(s) in Company
23rd Jul 20202:20 pmRNSResult of placing
23rd Jul 20207:27 amRNSProposed Placing to raise £25m
23rd Jul 20207:25 amRNSAcquisition of Talbot and Muir and Dunstan Thomas
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.